|Cat. No.||Species||Product Description||Structure||Purity||Feature|
|VEC-H4225||Human||Human VEGF-C / Flt4-L Protein, His Tag (MALS verified)||
Human VEGF-C, His Tag (Cat. No. VEC-H4225) captured on CM5 Chip via anti-His antibody can bind Human VEGF R3, Fc Tag (Cat. No. FL4-H5251) with an affinity constant of 41.1 pM as determined in SPR assay (Biacore T200) (Routinely tested).
The purity of Human VEGF-C, His Tag (Cat. No. VEC-H4225) is more than 95% and the molecular weight of this protein is around 32-42 kDa verified by SEC-MALS.
|Name||Research Code||Research Phase||Company||Indications||Clinical Trials|
|VEGF-C gene therapy (Herantis Pharma)||Ad-VEGF-C; LX-1101||Herantis Pharma||Details|
|Sozinibercept||OPT-302; VGX-300||Phase 3 Clinical||Orphan Europe Sarl||Neovascularization, Pathologic; Retinal Diseases; Diabetic macular oedema; Retinal Degeneration; Eye Diseases; Macular Degeneration||Details|
|IBI-333||IBI-333||Phase 1 Clinical||Innovent Biologics (Usa), Inc||Wet Macular Degeneration; Macular Degeneration||Details|
This web search service is supported by Google Inc.